U.S. Markets closed

Genmab IPO raises $582m, becoming second largest US IPO ever by a bio-tech company

International bio-tech company Genmab is on a mission to improve the life of cancer patients, after becoming the second largest U.S. IPO ever by a bio-tech company. Genmab CEO Jan van de Winkel joins Yahoo Finance's Adam Shapiro and Julie Hyman to discuss.